S'abonner

Parental Enrollment Decision-Making for a Neonatal Clinical Trial - 15/11/21

Doi : 10.1016/j.jpeds.2021.08.014 
Elliott Mark Weiss, MD, MSME 1, 2, , Katherine F. Guttmann, MD, MBE 3, Aleksandra E. Olszewski, MD 1, 2, Brooke E. Magnus, PhD 4, Sijia Li, BS 5, Scott Y.H. Kim, MD, PhD 6, Anita R. Shah, MD, MPH 7, Sandra E. Juul, MD, PhD 2, Yvonne W. Wu, MD, MPH 8, Kaashif A. Ahmad, MD, MSc 9, Ellen Bendel-Stenzel, MD 10, Natalia A. Isaza, MD 11, Andrea L. Lampland, MD 12, Amit M. Mathur, MBBS, MD, MRCP 13, Rakesh Rao, MD 14, David Riley, MD 15, David G. Russell, JD 16, Zeynep N.I. Salih, MD, MA 17, Carrie B. Torr, MD 18, Joern-Hendrik Weitkamp, MD 19, Uchenna E. Anani, MD 19, Taeun Chang, MD 20, Juanita Dudley, BSN 16, John Flibotte, MD 21, Erin M. Havrilla, MSN 19, Alexandra C. O’Kane, MS 22, Krystle Perez, MD, MPH 2, Brenda J. Stanley, MSN 23, Seema K. Shah, JD 24, Benjamin S. Wilfond, MD 1, 2
1 Treuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, WA 
2 Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 
3 Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 
4 Department of Psychology and Neuroscience, Boston College, Chestnut Hill, MA 
5 Department of Biostatistics, University of Washington School of Public Health, Seattle, WA 
6 Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD 
7 Division of Neonatology, Children’s Hospital of Orange County, Orange, CA 
8 Departments of Neurology and Pediatrics, University of California San Francisco School of Medicine, San Francisco, CA 
9 Department of Pediatrics, Baylor College of Medicine, San Antonio, TX 
10 Department of Pediatrics, Mayo Clinic, Rochester, MN 
11 Division of Neonatology, Department of Pediatrics, Children’s National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC 
12 Department of Neonatology, Children’s Minnesota Hospital, Minneapolis, MN 
13 Department of Pediatrics, Saint Louis University School of Medicine, St Louis, MO 
14 Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 
15 Department of Pediatrics, Cook Children’s Medical Center, Texas Christian University and University of North Texas Health Science Center School of Medicine, Fort Worth, TX 
16 Division of Neonatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 
17 Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN 
18 Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT 
19 Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 
20 Department of Neurology, Children’s National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC 
21 Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA 
22 Georgetown University School of Medicine, Washington, DC 
23 Pediatrix Medical Group, San Antonio, TX 
24 Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL 

Reprint requests: Elliott Mark Weiss, MD, MSME, Assistant Professor of Pediatrics, Division of Neonatology | University of Washington, Treuman Katz Center for Pediatric Bioethics | Seattle Children’s Hospital & Research Institute, 4800 Sand Point Way NE, M/S FA.2.113 Neonatology, Seattle, WA 98105Assistant Professor of PediatricsDivision of Neonatology | University of WashingtonTreuman Katz Center for Pediatric Bioethics | Seattle Children’s Hospital & Research Institute4800 Sand Point Way NEM/S FA.2.113 NeonatologySeattleWA98105

Abstract

Objective

To describe the parental experience of recruitment and assess differences between parents who participated and those who declined to enroll in a neonatal clinical trial.

Study design

This was a survey conducted at 12 US neonatal intensive care units of parents of infants who enrolled in the High-dose Erythropoietin for Asphyxia and encephaLopathy (HEAL) trial or who were eligible but declined enrollment. Questions assessed 6 factors of the parental experience of recruitment: (1) interactions with research staff; (2) the consent experience; (3) perceptions of the study; (4) decisional conflict; (5) reasons for/against participation; and (6) timing of making the enrollment decision.

Results

In total, 269 of 387 eligible parents, including 183 of 242 (75.6%) of those who enrolled their children in HEAL and 86 of 145 (59.3%) parents who declined to enroll their children in HEAL, were included in analysis. Parents who declined to enroll more preferred to be approached by clinical team members rather than by research team members (72.9% vs 49.2%, P = .005). Enrolled parents more frequently reported positive initial impressions (54.9% vs 10.5%, P < .001). Many parents in both groups made their decision early in the recruitment process. Considerations of reasons for/against participation differed by enrollment status.

Conclusions

Understanding how parents experience recruitment, and how this differs by enrollment status, may help researchers improve recruitment processes for families and increase enrollment. The parental experience of recruitment varied by enrollment status. These findings can guide future work aiming to inform optimal recruitment strategies for neonatal clinical trials.

Le texte complet de cet article est disponible en PDF.

Keywords : research participation, decisional conflict, enrollment decision-making

Abbreviations : HEAL, HIE, IRB, NICU


Plan


 Funded by Seattle Children’s Hospital Center for Clinical & Translational Research Clinical Research Scholars Program with additional support from Children’s Minnesota Research Grant Program and University of Washington Neonatal Bioresearch Fund. The funders had no control over design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. J-H.W. reports receiving fees as a consultant for Roche Diagnostics Corporation to help with development of a neonatal sepsis marker. The other authors declare no conflicts of interest.


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 239

P. 143 - décembre 2021 Retour au numéro
Article précédent Article précédent
  • Antibiotic Use in Neonatal Intensive Care Units in China: A Multicenter Cohort Study
  • Siyuan Jiang, Lan Zhang, Weili Yan, Shujuan Li, Junyan Han, Qi Zhou, Yi Yang, Shoo K. Lee, Yun Cao, REIN-EPIQ Study Group, Yong Ji, Shuping Han, Sannan Wang, Zhankui Li, Chuanzhong Yang, Changyi Yang, Shiwen Xia, Ling Chen, Ruobing Shan, Ling Liu, Bin Yi, Zhenlang Lin, Yang Wang, Jiangqin Liu, Ling He, Mingxia Li, Xinnian Pan, Yan Guo, Cuiqing Liu, Qin Zhou, Xiaoying Li, Hong Xiong, Yujie Qi, Mingyan Hei
| Article suivant Article suivant
  • Sustained Inflation Versus Intermittent Positive Pressure Ventilation for Preterm Infants at Birth: Respiratory Function and Vital Sign Measurements
  • Elizabeth E. Foglia, Haresh Kirpalani, Sarah J. Ratcliffe, Peter G. Davis, Marta Thio, Helmut Hummler, Gianluca Lista, Francesco Cavigioli, Georg M. Schmölzer, Martin Keszler, Arjan B. te Pas

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.